Linkage Global Appoints Biotechnology Expert Dr. Xunyong Zhou to Board Amidst Leadership Changes

summarizeSummary

Linkage Global Inc. announced changes to its Board of Directors, including the departure of two members and the appointment of Dr. Xunyong Zhou, an expert in biotechnology and health innovation.

check_boxKey Events

• Board Member Departures

  Mr. Zhiyong Wu and Mr. Ryo Fuyunishiki stepped down from the Board of Directors, effective February 13, 2026. Mr. Fuyunishiki will remain the Company's Chief Operating Officer.

• New Director Appointment

  Dr. Xunyong Zhou was appointed to the Board of Directors, effective February 13, 2026.

• New Director's Expertise

  Dr. Zhou brings over 6 years of experience in biotechnology and health innovation, holding over 20 patents. He has led advancements in biological enzyme solutions and cell therapy technologies, and oversees AI-enhanced health service teams.

auto_awesomeAnalysis

This filing details a significant board refresh for Linkage Global Inc., which is currently navigating severe financial challenges and a potential NASDAQ delisting. While two board members have stepped down, the appointment of Dr. Xunyong Zhou, a seasoned entrepreneur and researcher in biotechnology and health innovation, is a notable positive development. Dr. Zhou's extensive experience, including leadership roles in biological enzyme solutions and AI-enhanced health services, could bring crucial expertise and strategic direction to the company as it seeks to stabilize its operations and explore new growth avenues. This move suggests an effort to strengthen governance and potentially pivot strategy following recent poor financial results and a pending reverse stock split vote.